European Medicines Agency reaffirms safety and effectiveness of Gardasil HPV vaccine
23 September 2011
The European Medicines Agency (EMA) has responded to concerns expressed by Sane Vax Inc. and confirmed that the benefit-risk profile of Gardasil remains positive.
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has written to Sane Vax addressing the issues it raised.
Download EMA Letter